Pathologically, AD is characterized by the progressive loss of basal forebrain cholinergic neurons1, and neuropathological changes of abnormally accumulated extracellular amyloid-β peptide (Aβ)2 and intracellular tau protein3. The gene discussed is MAPT; the disease is Alzheimer disease.